BNP Paribas Financial Markets’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-182,817
| Closed | -$12.4M | – | 5000 |
|
|
2022
Q3 | $12.4M | Buy |
182,817
+169,220
| +1,245% | +$9.33M | 0.02% | 868 |
|
|
2022
Q2 | $434K | Buy |
13,597
+8,500
| +167% | +$249K | ﹤0.01% | 2729 |
|
|
2022
Q1 | $177K | Sell |
5,097
-7,872
| -61% | -$235K | ﹤0.01% | 3175 |
|
|
2021
Q4 | $380K | Buy |
12,969
+2,250
| +21% | +$69.7K | ﹤0.01% | 3144 |
|
|
2021
Q3 | $273K | Buy |
10,719
+5,519
| +106% | +$162K | ﹤0.01% | 2937 |
|
|
2021
Q2 | $182K | Buy |
5,200
+2,810
| +118% | +$110K | ﹤0.01% | 2889 |
|
|
2021
Q1 | $97.4K | Sell |
2,390
-1,970
| -45% | -$90.5K | ﹤0.01% | 3367 |
|
|
2020
Q4 | $189K | Buy |
4,360
+1,997
| +85% | +$98.5K | ﹤0.01% | 2913 |
|
|
2020
Q3 | $130K | Sell |
2,363
-14,626
| -86% | -$930K | ﹤0.01% | 2973 |
|
|
2020
Q2 | $1.07M | Sell |
16,989
-55,602
| -77% | -$3.81M | ﹤0.01% | 1777 |
|
|
2020
Q1 | $3.71M | Buy |
72,591
+62,535
| +622% | +$4.19M | 0.01% | 1128 |
|
|
2019
Q4 | $799K | Sell |
10,056
-18,379
| -65% | -$1.09M | ﹤0.01% | 2161 |
|
|
2019
Q3 | $1.38M | Buy |
28,435
+8,594
| +43% | +$448K | ﹤0.01% | 1697 |
|
|
2019
Q2 | $1.04M | Buy |
19,841
+7,319
| +58% | +$421K | ﹤0.01% | 1723 |
|
|
2019
Q1 | $663K | Buy |
12,522
+447
| +4% | +$22K | ﹤0.01% | 1921 |
|
|
2018
Q4 | $496K | Sell |
12,075
-43,701
| -78% | -$1.64M | ﹤0.01% | 1813 |
|
|
2018
Q3 | $2.12M | Sell |
55,776
-8,823
| -14% | -$391K | ﹤0.01% | 1465 |
|
|
2018
Q2 | $2.92M | Sell |
64,599
-75,352
| -54% | -$3.43M | ﹤0.01% | 1339 |
|
|
2018
Q1 | $6.76M | Buy |
139,951
+132,253
| +1,718% | +$7.38M | 0.01% | 862 |
|
|
2017
Q4 | $303K | Buy |
7,698
+3,353
| +77% | +$125K | ﹤0.01% | 2746 |
|
|
2017
Q3 | $135K | Sell |
4,345
-202
| -4% | -$5.68K | ﹤0.01% | 2644 |
|
|
2017
Q2 | $124K | Buy |
4,547
+3,975
| +695% | +$118K | ﹤0.01% | 2719 |
|
|
2017
Q1 | $21.1K | Sell |
572
-719
| -56% | -$18.1K | ﹤0.01% | 3005 |
|
|
2016
Q4 | $18.7K | Sell |
1,291
-138
| -10% | -$2.42K | ﹤0.01% | 3210 |
|
|
2016
Q3 | $32.9K | Buy |
1,429
+874
| +157% | +$16.7K | ﹤0.01% | 2627 |
|
|
2016
Q2 | $9.21K | Buy |
555
+441
| +387% | +$8.9K | ﹤0.01% | 2948 |
|
|
2016
Q1 | $1.81K | Sell |
114
-1,168
| -91% | -$20.8K | ﹤0.01% | 2431 |
|
|
2015
Q4 | $41.4K | Buy |
1,282
+1
| +0.1% | +$43 | ﹤0.01% | 2939 |
|
|
2015
Q3 | $54K | Buy |
+1,281
| New | +$60.4K | ﹤0.01% | 2800 |
|
Other funds holding GBT
BNP Paribas Financial Markets's GBT Position: Q4 2022 in Review
BNP Paribas Financial Markets sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 182,817 shares — an estimated $12.4M sold.
BNP Paribas Financial Markets first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $12.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- BNP Paribas Financial Markets reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 182,817 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $12.4M.
- BNP Paribas Financial Markets first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
- BNP Paribas Financial Markets's Global Blood Therapeutics, Inc. position peaked at $12.4M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.